Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
XENE Insider Trading and Fund Holdings (Xenon Pharmaceuticals Inc.) · https://wallstpal.com/stock/xene/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1582313

Xenon Pharmaceuticals Inc. (XENE): Insider Trades and Fund Holdings

In the past 12 months, Xenon Pharmaceuticals Inc. insiders reported 2 open-market purchases worth $1.68M and 2 sales worth $1.07M; 1 of the sales were reported as made under a 10b5-1 trading plan.

2Insider buys, 12 months
$1.68MBought by insiders, 12 months
$1.07MSold by insiders, 12 months
2Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Sep 30, 2026Insider buyCEO Ian Mortimer bought $1.1 million
  2. Sep 30, 2026Insider buyCFO Thomas Patrick Kelly bought $559,740
  3. Aug 28, 2026Insider saleChief Medical Officer Christopher John Kenney sold $425,829 under a 10b5-1 plan
  4. Aug 28, 2026Planned saleCHRISTOPHER KENNEY (officer) filed notice to sell about $437,721 around Aug 28, 2026
  5. Aug 13, 2026Planned saleSTEVEN GANNON (director) filed notice to sell about $640,553 around Aug 11, 2026
  6. Aug 11, 2026Insider saleDirector Steven Gannon sold $640,550 (5 days after: quarterly or annual results)
  7. Aug 6, 2026NewsCompany reported: Quarterly or annual results
  8. Jun 30, 2026FundRenaissance Technologies cut 38% in Q2 2026 (13F filed Aug 13, 2026)

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 1, 2026.

Recent XENE insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHoldingFiling
Oct 1Sep 30Ian MortimerCEOCEO▲ BUY30,00037.38$1.12M61+151%Form 4 ↗
Oct 1Sep 30Thomas Patrick KellyCFOCFO▲ BUY15,00037.32$560K58NewForm 4 ↗
Aug 31Aug 28Christopher John KenneyChief Medical OfficerChief Medical Officer▼ SELL10b5-17,06860.25$426K−100%Form 4 ↗
Aug 13Aug 11Steven GannonDirectorDirector▼ SELL10,00064.06$641K−84%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Ian MortimerCEO1$1.12M0$0Oct 1, 2026
Thomas Patrick KellyCFO1$560K0$0Oct 1, 2026
Christopher John KenneyChief Medical Officer0$01$426KAug 31, 2026
Steven GannonDirector0$01$641KAug 13, 2026
Strongest purchase, 12 months

61 Ian Mortimer (CEO), 2026-09-30. What the score means

Tracked funds that report XENE

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 2026187,110$11.3M0.02%▼ −37.7%
Duquesne Family OfficeQ2 2026238,600$14K0.33%No change
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →